Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

June 21, 2023

Study Completion Date

August 30, 2023

Conditions

Major Depressive Disorder

Interventions

DRUG

Escitalopram Pill

Double-blinded, randomly assigned

OTHER

Placebo

Double-blinded, randomly assigned

DRUG

Levomilnacipran Pill

Double-blinded, randomly assigned

Trial Locations (1)

University of Pittsburgh, Pittsburgh

All Listed Sponsors

collaborator

Weill Cornell Institute of Geriatric Psychiatry

UNKNOWN

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Howard Aizenstein

OTHER

NCT03128021 - Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO) | Biotech Hunter | Biotech Hunter